These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 25421829

  • 21. Risk of major bleeding and the standard doses of dabigatran.
    Antoniazzi S, Berdaï D, Conti V, Clementi E, Salvo F.
    Eur J Intern Med; 2014 Jul; 25(6):e73-5. PubMed ID: 24629895
    [No Abstract] [Full Text] [Related]

  • 22. Dabigatran and postmarketing reports of bleeding.
    Southworth MR, Reichman ME, Unger EF.
    N Engl J Med; 2013 Apr 04; 368(14):1272-4. PubMed ID: 23484796
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study.
    Abraham NS, Singh S, Alexander GC, Heien H, Haas LR, Crown W, Shah ND.
    BMJ; 2015 Apr 24; 350():h1857. PubMed ID: 25910928
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial analysis.
    Hijazi Z, Hohnloser SH, Oldgren J, Andersson U, Connolly SJ, Eikelboom JW, Ezekowitz MD, Reilly PA, Siegbahn A, Yusuf S, Wallentin L.
    Circulation; 2014 Mar 04; 129(9):961-70. PubMed ID: 24323795
    [Abstract] [Full Text] [Related]

  • 30. Dabigatran for stroke prevention in all patients with atrial fibrillation?
    Hunchuck JE, Lake JD.
    Pharmacotherapy; 2011 Aug 04; 31(8):725-8. PubMed ID: 21923597
    [No Abstract] [Full Text] [Related]

  • 31. Intensity and quality of warfarin anticoagulation in Chinese patients: setting the record straight.
    Eikelboom JW, Hart RG.
    Stroke; 2015 Jan 04; 46(1):5-6. PubMed ID: 25406147
    [No Abstract] [Full Text] [Related]

  • 32. Response to letter regarding article, "Management and outcomes of major bleeding during treatment with dabigatran or warfarin".
    Majeed A, Hwang HG, Connolly SJ, Eikelboom JW, Ezekowitz MD, Wallentin L, Brueckmann M, Fraessdorf M, Yusuf S, Schulman S.
    Circulation; 2014 Sep 02; 130(10):e95. PubMed ID: 25210103
    [No Abstract] [Full Text] [Related]

  • 33. Evaluation of dabigatran bleeding adverse reaction reports in the FDA adverse event reporting system during the first year of approval.
    McConeghy KW, Bress A, Qato DM, Wing C, Nutescu EA.
    Pharmacotherapy; 2014 Jun 02; 34(6):561-9. PubMed ID: 24644100
    [Abstract] [Full Text] [Related]

  • 34. Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin.
    Berger R, Salhanick SD, Chase M, Ganetsky M.
    Ann Emerg Med; 2013 Apr 02; 61(4):475-9. PubMed ID: 23522810
    [Abstract] [Full Text] [Related]

  • 35. Letter by Hifumi et al regarding article, "Management and outcomes of major bleeding during treatment with dabigatran or warfarin".
    Hifumi T, Takada H, Kiriu N.
    Circulation; 2014 Sep 02; 130(10):e94. PubMed ID: 25210102
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Response to letter regarding article, "Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control".
    Chan PH, Hai JJ, Siu CW.
    Stroke; 2015 Mar 02; 46(3):e72. PubMed ID: 25649808
    [No Abstract] [Full Text] [Related]

  • 38. Letter by Feng et al regarding article, "Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control".
    Feng X, Huan Y, Lv Y.
    Stroke; 2015 Mar 02; 46(3):e71. PubMed ID: 25649800
    [No Abstract] [Full Text] [Related]

  • 39. Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion.
    Nagarakanti R, Ezekowitz MD, Oldgren J, Yang S, Chernick M, Aikens TH, Flaker G, Brugada J, Kamensky G, Parekh A, Reilly PA, Yusuf S, Connolly SJ.
    Circulation; 2011 Jan 18; 123(2):131-6. PubMed ID: 21200007
    [Abstract] [Full Text] [Related]

  • 40. [New oral anticoagulants - sunset for warfarin in therapy of atrial fibrillation].
    Koziński M, Obońska K, Kubica A, Navarese EP, Kubica J.
    Kardiol Pol; 2012 Jan 18; 70(10):1053-60. PubMed ID: 23080100
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.